CeliaRx Tirzepatide Review: Injection, ODT and Membership Terms

CeliaRx now publishes distinct compounded tirzepatide/B12 injection products and orally disintegrating tirzepatide tablets. The injection listings name 34mg/4mg and 68mg/8mg vial totals; oral listings name 4mg and 8mg tablets. These are different product configurations, not interchangeable dose choices. The presence of an oral product is useful for comparing what the storefront offers, but it does not establish the absorption or outcomes achieved by approved injected tirzepatide.¹²³⁴⁵⁶

This review uses public program and contract information checked October 17, 2026. We did not purchase medication, submit a medical intake or test a clinical service. Published program features are distinguished from the questions an individual patient still needs answered.

What the published prices actually cover

The current directly retrieved catalog lists the 34mg/4mg injection at $549 and the 68mg/8mg injection at $699. The smaller vial page describes approximately two months of supply, which remains dependent on the prescription. The same injection pages also contain $350-per-month and $225-per-month descriptions that do not reconcile clearly with the displayed vial totals. Those competing descriptions require a written selected-order quote. The ODT products are $299 and $499 respectively. An onboarding consultation is separately listed at $55 for 15 minutes. These are product amounts, not a universal flat monthly treatment cost; do not divide a vial into months without the actual weekly dose and usable supply.¹²³⁴⁵⁶

Compare the amount due today with the quantity that a prescriber actually expects you to use before the next shipment. A vial total, an installment, a consultation fee and a monthly equivalent describe different things. Ask for one itemized order showing those components together, including what changes at renewal. A medicine advertised at a lower entry dose is not a useful price comparison for a different prescribed dose or a longer commitment.

How clinical access and fulfillment work

The product pages require a licensed-provider consultation and say a medically unsuitable patient receives a full refund. The injection page names Partell Pharmacy as the compounder. This is a published dispensing relationship, not independent verification of the pharmacy’s license, actual patient assignment or a batch test. Confirm the assigned legal pharmacy name, permitted state service and whether the consultation fee is included or separate for the order selected.¹²³⁴⁵⁶

Before treatment, establish who answers clinical messages and who handles billing or shipping questions. They may be different teams. Ask how a new symptom reaches the prescriber, whether another visit is needed for a dose change, and which phone or portal to use if a shipment is delayed. A care feature only becomes useful when its scope and access match the service you need; a generic support promise does not supply a measured response-time guarantee.

Cancellation, refunds and repeat orders

Platform terms describe a membership-based community, generally nonrefundable transactions and no credit for partly used membership. Canceling membership preserves access through its remaining term and does not refund prepaid fees. That general language needs to be read alongside the product-specific medical-denial refund statement. A storefront purchase, a membership and a clinical consultation can have different conditions; ask which ones apply to a particular prescription rather than assuming the most favorable rule covers every charge.¹²³⁴⁵⁶

Keep the selected terms and the date of any cancellation request. Stopping future care, reversing an initial order and requesting a remedy for the wrong product are separate events. If treatment is paused or stopped for medical reasons, ask what happens to any already processed prescription, prepaid visit or remaining installment. The published policy should be clarified before payment where those events lead to different financial outcomes.

Product claims and the remaining limits

Fresh direct product text differs from older indexed monthly-price wording. This review uses the current direct product amounts and preserves the distinction between total vial content and time supplied. B12 inclusion and product benefit language do not establish superiority over an approved medicine. Tablet strengths also cannot be converted into injectable strengths by matching milligrams.¹²³⁴⁵⁶

FDA explains that compounded GLP-1 medicines are not FDA-approved and do not undergo its premarket review for safety, effectiveness or quality. Its advice is to consider compounding when an individual patient’s medical needs cannot be met by an approved drug. A clinic’s service description, a pharmacy relationship and a published clinical trial answer different questions; none alone verifies the quality or expected result of a particular compounded prescription.⁷

How to compare this option

For CeliaRx, the strongest comparison starts with the specific arrangement described above: the treatment offered, the form of clinical access and the payment commitment. Treat unresolved details as questions for the provider, rather than assuming either the most favorable or the most restrictive possible answer. Ask for the medicine and formulation in writing, then compare the same dose and days supplied with another appropriate care option.

Compare the published agreements in our Gide Health review and Robinhood Telehealth review. Their inclusion is a comparison route, not a ranking or a recommendation for a particular prescription.

Our care-options guide explains the difference between a prescriber, pharmacy and access platform. The Zepbound cost guide helps compare approved-product pathways, while other provider reviews show why a similar headline can hide a different contract. If an oral or microdose option is proposed, use the oral tirzepatide guide or microdosing guide to frame evidence questions with your clinician. Neither a low starting amount nor a broad wellness menu determines which prescription is appropriate for you.

Vial supply and use after opening

The advertised multi-month supply needs a separate safety check. FDA currently recommends discarding multidose sterile vials within 28 days of first use, even when a compounder gives longer instructions. Ask the prescriber and dispenser how the actual shipment and vial quantities meet that guidance; an approximate two-month marketing supply is not permission to use one opened vial for two months.⁷

To compare why injection and oral listings need separate quantity and cost comparisons, see Nu Image and Rixa.